Immunoblotting and Goldmann-Witmer Coefficient for Ocular Toxoplasmosis
- Conditions
- Ocular Toxoplasmosis
- Interventions
- Procedure: Aqueous humour sampling
- Registration Number
- NCT03948750
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
Ocular toxoplasmosis (OT) is a common cause of posterior uveitis worldwide. The diagnosis of OT is based on clinical findings, but in most cases, laboratory tests are required to confirm the etiology, especially when other diseases are suspected. The aim of this study was to evaluate which methods, between the Goldmann-Witmer coefficient (GWC) and immunoblotting (IB) with both IgG and IgA, in aqueous humour (AH) samples, can be the most sensitive to diagnose OT, in current practice, especially in the first three weeks.
- Detailed Description
Goldmann-Witmer coefficient (GWC): compares the levels of intraocular antibody (igG) production to that serum, as measured by ELISA.
GWC = (Level of specific IgG in aqueous humour/level of specific IgG in serum)/(Total IgG in aqueous humour/Total IgG in serum)
0.5 to 2: No intraocular antibody production, 2 to 4: Suggestive of intraocular antibody production, \> 4: Diagnostic of intraocular antibody production to a specific microbial pathogen
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 87
- Patients who had underwent aqueous humor and serum sample for ocular toxoplasmosis diagnosis
- Immunocompromised patients
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with Ocular Toxoplasmosis Aqueous humour sampling - Patients without Ocular Toxoplasmosis Aqueous humour sampling -
- Primary Outcome Measures
Name Time Method Comparison of Goldmann-Witmer coefficient and immunoblotting results Assessment of each test result at the inclusion of the patient All tests realized in patients were performed before their repartition in the two groups as well as the biologist could not know the status of the patient. Sensitivity and specificity were calculated for each test.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Service d'ophtalmologie, Hôpital de la Croix-Rousse (HCL)
🇫🇷Lyon, France